Rhonda Ries

20PUBLICATIONS

194CO-AUTHORS

Haematological tumoursGene and molecular therapyMedical infection agents (incl. prions)Molecular targetsInfant and child health

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|May 12, 2026

Clinical implications of RAS mutations in AML: Prognostic significance is based upon involved gene and mutation complexity.

|May 05, 2026

Combining Menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia.

|Apr 07, 2026

DLK1 is a GATA1s-driven dependency and therapeutic target in Down syndrome-associated myeloid leukemia.

Lonneke Verboon, Sonali P Barwe, Meredith Tavenner

|Dec 06, 2025

Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia.

Ke Wang, Shayan Saniei, Nikita Poddar

|Nov 24, 2025

Prognostic impact of age and MDS-associated mutations in <i>NPM1</i> -mutated AML.

Vivian M Liu, Megan Othus, Jasmine Naru

|Sep 08, 2025

Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma.

Michelle Choe, Danielle Kirkey, Isabel Lira

Pageof 4

Frequent Collaborators

Soheil Meshinchi

Xiaotu Ma

Jeffery M Klco

Benjamin J Huang

Jatinder Lamba

Jenny L Smith

Jack H Peplinski

Jason Farrar

Timothy Triche

Nam Nguyen

Frequent Collaborators

Soheil Meshinchi

Xiaotu Ma

Jeffery M Klco

Benjamin J Huang